The Rhizobium meliloti nifA product (NifA) shares extensive homology in its central region and at its C-terminal end with Rhizobium leguminosarum DctD and with NtrC from several species. All three proteins are transcriptional activators of NtrA (RpoN)-RNA polymerase-dependent promoters. Several large deletions of R. meliloti NifA were constructed to investigate the role of the conserved and divergent domains of NifA in transcriptional activity and posttranscriptional regulation by oxygen. The ability of NifA expressed from the Escherichia coli lacZ promoter to activate the R. meliloti nip promoter in E. coli and R. meliloti was tested under a range of defined atmospheric oxygen partial pressures. Deletion of the divergent N-terminal domain of NifA had little effect on NifA activity and no effect on oxygen sensitivity. Deletion of the conserved C-terminal helix-turn-helix motif of NifA did not eliminate NifA-dependent activation of the nifH promoter, although it did decrease NifA activity about twofold in E. coil and 10-fold in R. meliloti. A NifA carrying both the N-terminal and C-terminal deletions and consisting of only the central highly conserved domain and 50 divergent amino acids retained the ability to activate transcription from the niJU promoter. The transcriptional activity of the conserved central domain is consistent with the prediction that the core domain is the part of NifA which interacts with the transcriptional machinery to stimulate transcription.
K. pneumoniae nifA in pACYC177 lacZ'-nifA in pSDC13 (NifAAUGlac) lacZ'-nifA in pSDC13 (NifA-AUG1) lacZ'-nifA in pSDC13 (NifA-AUG2) lacZ'-nifA in pSDC13 (NifA-AN) IacZ'-nifA in pHAT1 (NifA-AC) lacZ'-nifA in pHAT1 (NifA-ANAC) pEH301 fusion up to EcoRI site in pMC1403 pEH32 fusion up to EcoRI site in pMC1403 pEH29 fusion up to EcoRI site in pMC1403 Cmr, M13 ori, ColEl ori, termination codons in three frames Tcr lacZ'-1acZ, RK2 ori Apr ColEl ori, lacZY fusion vector Tcr nifH'-lacZ fusion, RK2 ori Kmr nifH'-lacZ fusion, ColEl ori Cmr, M13 ori, ColEl ori Tcr nifH'-lacZ in pSUP202 Smr Spr derivative of pWB5A, RK2 ori lacZ'-nifA in pSPC1 (NifAAUGlac) lacZ'-nifA in pSPC1 (NifA-AUG1) lacZ'-nifA in pSPC1 (NifA-AUG2) lacZ'-nifA in pSPC1 (NifA-AN) lacZ'-nifA in pSPC1 (NifA-AC) lacZ'-nifA in pSPC1 (NifA-ANAC) Klenow fragment and calf intestinal phosphatase were from Boehringer Mannheim, and T4 ligase was from New England BioLabs. Bacterial strains and plasmids used in this study are listed in Table 1 . LB medium (27) and TY medium (28) have been previously described. Antibiotic concentrations used for E. coli were 10 ji.g/ml for tetracycline, 25 ,ug/ml for kanamycin, 20 ,ug/ml for streptomycin, 50 ,ug/ml for spectinomycin, 25 ,ug/ml for chloramphenicol, and 100 jig/ml for ampicillin. For R. meliloti, antibiotic concentrations were 5 ,ug/ml for tetracycline, 300 ,ug/ml for streptomycin, 100 ,ug/ml for spectinomycin, and 100 ,ug/ml for neomycin.
Construction of nifA driver plasmids. DNA manipulations, including restriction digestions, removal of terminal phosphates with calf intestinal phosphatase, filling out staggered ends with Klenow fragment, and ligation with T4 ligase, were carried out as previously described (26) . Plasmid pCE301 (5.6 kilobases) contains a translational fusion that joins the promoter and first seven amino acids of E. coli lacZ to the second amino acid residue of R. meliloti nifA. The fusion was constructed by ligating a filled-in HindIII end from the HindlIl site located within codon 8 of the lacZ coding region in pUC13 to a blunt-ended MstI site located within codon 2 of nifA (the coding region begins 412 bases from the HindIII site in pCE301) (C. Earl, Ph.D. thesis, Harvard University, Cambridge, Mass., 1986; see Table 1 and Fig. 1A ). We cloned a 2.4-kilobase PvuII fragment from pCE301, containing the lacZ'-nifA translational fusion, into a filled-in BglII site in ITAN7 (23) . The resulting plasmid, 7r301, contains the original lacZ'-nifA translational fusion flanked by a SmaI and a HindlIl site. Following digestion of 1T301 with SmaI and HindIII and filling in of the HindIII end, the fragment bearing the fusion gene was used to replace the SacIl fragment of pSDC13 (25) which encodes the lacZa fragment to produce pEH301. The fusion gene carried on pEH301 is flanked by unique PstI and XbaI sites. pEH301 also carries an M13 origin of replication, making this plasmid useful for mutagenesis schemes requiring single-stranded
DNA.
An oligonucleotide-directed in vitro mutagenesis kit (Amersham Corp.) was used to reconstruct the N-terminal end of NifA to the wild-type sequence and to create a precise translational fusion at the first AUG codon of nifA carried on pEH301. The oligonucleotide used for the mutagenesis (5'-ACAGGAAACAGCTATGCGCAAACAGGACAAG-3') included 13 nucleotides of untranslated lacZ mRNA and the first start codon of lacZ followed by 16 nucleotides of the nifA coding region beginning with codon 2. Several mutagenized plasmids were sequenced by the dideoxy method (40) , and one containing the correct fusion sequence to the first AUG codon was named pEH32. Plasmid pEH29 was created by oligonucleotide-directed mutagenesis of pEH301 as described for pEH32, except that the oligonucleotide 5'-ACAGGAAACAGCTATGGCCCCCACTCGTC-3' was used, which carries a fusion junction between the lacZ promoter and R. meliloti nifA at the second in-frame AUG start codon of nifA (10) . The lacZ'-nifA fusions in pEH32 and pEH29 carry the ribosome-binding site of lacZ but contain no amino acids from lacZ, since the fusion junction is within the lacZ initiation codon.
Deletion of the N-terminal domain of nifA was accomplished by cloning an EcoRI-XmaI fragment containing the central and C-terminal domains of nifA from pCE301 into the pUC18 polylinker. To create pEHAR1, a PvuII fragment carrying the lacZ promoter fused to the N-terminal-deleted nifA gene was cloned between the filled-out BamHI and XbaI sites of pEH32, replacing the fragment containing the lacZ promoter fused to nifA at the first AUG codon with a fragment containing the lacZ promoter, initiation codon, and five additional codons fused to nifA at codon 180 of nifA.
The vector pHAT1 was created by replacing the SacIl fragment of pSDC13 carrying the lacZ promoter and alpha fragment of lacZ with a new polylinker (5'-CGGCCGC TCTAGAAGCTTGGATCCCCGGGTAAGTAACTAAGGC CTCTGCAGCGGCCGC-3') which contains stop codons in all three reading frames, ensuring that translation will not continue beyond the end of a gene fragment which is inserted into the polylinker in a left-to-right orientation. This vector was used in the construction of plasmids pEH101 and pEH200. A translational fusion between the lacZ promoter and the central domain of nifA (pEH101) was created by VOL. 171, 1989 cloning the 0.9-kilobase EcoRI-to-BamHI fragment, spanning amino acids 180 to 489 of nifA, into pUC18. The PvuII-to-BamHI fragment which carried the new lacZ'-nifA fusion was recloned into the SmaI site of the vector pHAT1 to create pEH101. The NifA protein produced from this plasmid is missing 180 amino acids from the N-terminal end and 52 amino acids from the C-terminal end. To create a fusion between the lacZ promoter and nifA in which only the C-terminal end of the protein had been deleted (pEH200), a BamHI fragment from pEH32 carrying the lacZ promoter and all but the C-terminal domain of nifA was ligated into the BamHI site of pHAT1. Both pEH101 and pEH200 contain nifA in an orientation which causes the NifA protein to terminate at the stop codons contained in the polylinker of pHAT1, resulting in proteins which terminate within two codons of the BamHI site contained in nifA.
Construction of 1acZ'-nifA-1acZ fusions. Plasmid pEH301 was digested with BamHI and EcoRI, and the ends were filled out. The fragment from pEH301 which contained the lacZ promoter and the N-terminal domain of nifA was ligated into the filled-out XmaI site of pMC1403 (11) to create an in-frame fusion between the N-terminal domain of nifA and lacZ, yielding pEH3011ac. The same method was used to create pEH321ac and pEH291ac from pEH32 and pEH29, respectively.
Construction of broad-host-range nifA driver plasmids. Plasmid pSPC1 is a derivative of pWBSA (W. Buikema and F. M. Ausubel, unpublished results), an RK2-based vector which is capable of replicating in both E. coli and R. meliloti and which carries a polylinker from ITVX (26) cloned into the EcoRI site of pRK290 (16) . Plasmid pSPC1 was created by replacing a SmaI fragment which contained most of the tetracycline resistance gene of pWB5A with a SmaI fragment from plasmid pHP45fQ (33) , which carries a gene conferring resistance to both streptomycin and spectinomycin.
The fusion genes in pEH301, pEH32, pEH29, and pEHAR1 are each flanked by unique XbaI and PstI sites. Plasmids pSPC301, pSPC32, pSPC29, and pSPCAR1 were created by ligating this XbaI-PstI fragment into the polylinker of pSPC1. Plasmid pSPC102 was created in two steps to produce a plasmid with the lacZ'-nifA fusion in an orientation consistent with the others. In the first step, the lacZ'-nifA fusion from pEH101 was digested with StuI and BamHI, the BamHI end was filled in, and the fragment was ligated into the HincII site of pUC19. In the second step, the intermediate plasmid was digested with PstI and XbaI and ligated into the polylinker of pSPC1. Plasmid pSPC200 was created by ligating a PstI fragment carrying the lacZ'-nifA fusion into the PstI site of pSPC1 and selecting a ligation product with the lacZ'-nifA fusion in the desired orientation.
Other plasmids. The reporter plasmid pMB210, which contains a translational fusion of the R. meliloti nifH promoter to the E. coli lacZ gene on an RK2 replicon, has been previously described (5) . The reporter plasmid pEH9 is a kanamycin-resistant derivative of pVSP9, which contains a translational fusion of the R. meliloti nifH promoter to the E. coli lacZ gene on a ColEl replicon (44 pneumoniae nifA gene cloned into pACYC177, has been previously described (35) . Construction of Rm4000. The suicide plasmid pSHL, bearing an R. meliloti nifH'-lacZ fusion and incapable of replicating in R. meliloti, was created via a three-way ligation.
The three fragments used in the ligation included a 6.9-kilobase EcoRI-SalI fragment containing the nifH'-lacZ fusion gene from pVSP9-1 (44), pSUP202 (41) linearized with EcoRI, and a small EcoRI-SalI fragment from the polylinker region of M13mpl8 (47) .
To integrate the nifH'-lacZ fusion into the R. meliloti chromosome, pSHL was mobilized into Rm1354, a nifA:: TnS mutant derivative of RmlO21 (48) . Six tetracyclineresistant, streptomycin-resistant colonies were picked and examined by Southern blot analysis (14) for the presence of a copy of pSHL integrated at nifH. All six contained the integration (data not shown). One of these was designated Rm4000 .
Culture conditions and I-galactosidase assays. All assays in E. coli were carried out in YMC21 (ntrC) to avoid activation of the nifH promoter by E. coli ntrC. Overnight cultures of E. coli YMC21 containing the appropriate plasmids were grown from fresh colonies at 37°C in LB medium containing 0.2% glutamine and appropriate antibiotics and diluted 1:100 in 10 to 20 ml of fresh LB medium plus glutamine and antibiotics in 250-ml flasks. Cultures were grown aerobically at 28°C on a rotary shaker to an optical density at 600 nm of 0.1 to 0.5 (approximately 5 h) and diluted to an optical density at 600 nm of 0.1 in the same medium, and 3-ml samples were pipetted into sterile culture tubes (25 by 250 mm) stoppered with sterile two-hole rubber stoppers. A sterile glass disposable 1-ml pipette containing a cotton plug had been previously inserted through one hole of each rubber stopper and adjusted so that the lower end of the pipette was 1 to 2 mm from the bottom of each tube, and the other hole had been plugged with sterile cotton. The tubes were placed in a water bath at 28°C, and plastic tubing (Tygon) was used to connect the 1-ml pipettes projecting above the rubber stoppers to tanks containing 5% CO2 and 95% N2 or 5% C02, 5% 02, and 90% N2 or to an air pump (21% 02). The flow of gas was regulated by using rotameters (Matheson Scientific, Inc.) to achieve a constant flow rate of 100 cm3/min per tube. Gas mixtures intermediate between 0 and 5%02 and between 5 and 21%02 were achieved by adjusting the flow rate of two gas mixtures into a Y-type connector (Nalgene Labware Div., Nalge/Sybron Corp.) attached to the inlet tubing according to the desired final oxygen partial pressure. The cultures were grown under these atmospheric conditions for 16 h and assayed for ,-galactosidase activity at 28°C as previously described (28 B.
- (Schoeffel Instruments) to estimate the relative amount of NifA present. The area under the peak corresponding to NifA and the total area under the scan trace were cut out and weighed to estimate the fraction of the total protein corresponding to NifA. For immunodetection, proteins were electrophoretically transferred to nitrocellulose, and detection was carried out essentially as previously described (7), using an anti-K. pneumoniae NifA antiserum which was generously provided by Martin Buck. The secondary antibody was goat anti-rabbit immunoglobulin G conjugated to alkaline phosphatase (Calbiochem-Behring). The relative amount of protein produced from each nifA plasmid was estimated by comparison with a standard curve of NifA from pSPC301 in E. coli YMC21 or in R. meliloti Rm4000 grown at 1% oxygen as described for ,-galactosidase assays.
RESULTS
Construction of precise lac'-nifA translational fusions. All nifA sequences published to date contain two AUG codons near the start of the open reading frame (10, 17, 20, 31, 46) . In R. meliloti WnfA, the second AUG codon occurs within 18 codons of the first codon, and both AUG codons have relatively weak potential ribosome-binding sites (42) . In this article, we assign codon numbers to nifA assuming that translation begins at the first AUG. Plasmid pEH301 carries a translational fusion between the E. coli lacZ promoter and R. meliloti nifA joining the first eight codons of lacZ to codon 3 of nifA (Earl, Ph.D. thesis). This fusion protein will be referred to as NifA-AUGlac. To eliminate the extra amino acids originating from 3-galactosidase present at the Nterminal end of NifA-AUGlac, we carried out oligonucleotide-directed mutagenesis of pEH301 to create two new fusions between the lacZ promoter and nifA (see Materials and Methods and Fig. 1A ). In these two precise translational fusions, the fusion junction occurs within the start codon of lacZ and the first potential start codon of nifA (pEH32; gene product NifA-AUG1) or the second potential start codon of nifA (pEH29; gene product NifA-AUG2).
Alteration of the N-terminal end of NifA greatly increases NifA accumulation in E. coli. The three plasmids pEH301, pEH32, and pEH29 differ only at the start of the nifA coding region and contain identical lacZ promoters and ribosomebinding sites up to the translational start point (Fig. 1) . To verify that each of these plasmids directs the synthesis of a NifA protein that accumulates in E. coli to approximately the same level, total E. coli protein extracts of E. coli YMC21 carrying each of the three plasmids were compared by SDS-polyacrylamide gel electrophoresis. Surprisingly, we found large differences in the levels of NifA accumulation among the three strains ( Fig. 2A) . NifA-AUGlac and NifA-AUG2 accumulated to high levels, up to 3% of the total protein in cells grown in an atmosphere containing 1% oxygen. In contrast, NifA-AUG1 was not visible by Coomassie staining but was detectable by Western (immuno-) blotting. The accumulation of NifA-AUG1 was estimated to be about 20-fold lower than the accumulation of NifAAUGlac by titration on Western blots (data not shown).
To test the properties of each NifA gene product in R. meliloti, the lacZ'-nifA fusions were also transferred to the low-copy-number plasmid pSPC1, containing an RK2 origin of replication. The resulting plasmids, pSPC301, pSPC32, and pSPC29, were tested for NifA accumulation in both E. coli and R. meliloti. As was the case with the high-copynumber plasmids, accumulation of NifA-AUGlac and NifA-AUG2 in E. coli YMC21 was detectable by Coomassie staining (1.4 and 1.2%, respectively, of total E. coli protein; data not shown), whereas NifA-AUG1 was detectable only on Western blots (at about a fivefold lower level than NifA-AUGlac and NifA-AUG2; Fig. 3A , compare lane 3 with lanes 2 and 4). In R. meliloti, NifA protein produced from pSPC301, pSPC32, and pSPC29 was detectable only by Western blotting (Fig. 3B , lanes 2 to 4 and 8 to 10). There was no detectable difference between the levels of NifA-AUG1 and NifA-AUGlac in R. meliloti, whereas NifA-AUG2 accumulated to a level twofold higher than NifA-AUG1.
To determine whether the differences in accumulation of NifA-AUGlac, NifA-AUG1, and NifA-AUG2 in E. coli were due to differences in the rate of translation, we constructed additional fusion proteins that contained the N-terminal domains of NifA-AUGlac, NifA-AUG1, and NifA-AUG2 fused to amino acid 8 of E. coli ,B-galactosidase (,-gal). No difference in accumulation between NifA-AUG1::3-gal and NifA-AUG2: :,8-gal was seen on Coomassie-stained SDSpolyacrylamide gels of total protein from E. coli MC1061 (Fig. 4) (19) . We tested the ability of R. meliloti NifA expressed from the lacZ promoter in E. coli YMC21 to activate expression of the nif'-lacZ reporter fusion carried on plasmid pMB210 under a range of constant atmospheric oxygen partial pressures ranging from 0 to 21%.
The maximum activity for all NifA fusions tested in E. coli occurred between 1 and 5% oxygen ( Fig. SA and B) . NifA-AUGlac, NifA-AUG1, and NifA-AUG2 produced approximately the same amount of 3-galactosidase activity from pMB120 at 1 to 3% oxygen, despite a 20-fold difference in accumulation. Activity from NifA-AUG1 fell off more sharply at higher oxygen partial pressures than activity from NifA-AUGlac and NifA-AUG2. At an oxygen partial pressure of 15% or higher, NifA-AUG1 was not capable of increasing expression from the nifH promoter above its basal level (Fig. SA) , retaining less than 0.3% of its maximum activity at 1% oxygen. In contrast, NifA-AUGlac and NifA-AUG2 retained about 10% of their maximum activities, even at 21% oxygen.
The broad-host-range plasmids pSPC301, pSPC32, and pSPC29 were also tested for NifA activity in E. coli YMC21 under a range of oxygen partial pressures. Plasmid pEH9, carrying a nifH'-lacZ fusion on a ColEl replicon, was used to monitor NifA activity for these plasmids. Although the maximum 3-galactosidase activity was about twofold lower for these experiments, the effect of oxygen on NifA activity remained about the same (Fig. SB) . The low level of constitutive P-galactosidase activity from the R. meliloti nifH promoter in the absence of any NifA showed no significant sensitivity to a high atmospheric oxygen level. Activation of the R. meliloti nifH promoter by K. pneumoniae NifA (pGR397) (35) also was not reduced by a high oxygen level in the absence of NifL, the mediator of NifA activity in response to oxygen in K. pneumoniae (22) (Fig. 5C ). The lack of oxygen sensitivity in both basal expression and K. pneumoniae NifA-mediated expression from the R. meliloti nifH promoter suggests that oxygen sensitivity is a property of R. meliloti NifA, rather than a property of the R. meliloti nifH promoter. The insensitivity of nifH expression to oxygen in the presence of pGR397 also suggests that the copy number of a plasmid such as pGR397 carrying a ColEl origin of replication is not substantially affected by variations in oxygen partial pressure between 3 and 21%. We also tested the possibility that the lacZ promoter itself or the copy number of the reporter plasmid pMB210 was affected by the oxygen partial pressure by measuring the expression of a reconstructed lacZ gene the lacZ promoter from M13mpl8 (47) to create pLAC. This plasmid showed no change in expression of lacZ between 0.5 and 21% oxygen (Fig. SC) .
NifA activity from pSPC301, pSPC32, and pSPC29 was also measured in R. meliloti, using strain Rm4000, which contains a nifHl'-lacZ reporter fusion integrated into the endogenous symbiotic plasmid (pRmeSU47a). In R. meliloti, NifA-AUGlac, NifA-AUG1, and NifA-AUG2 all accumulated to about the same level (Fig. 3B) . In addition, Igalactosidase activity rose to a maximum of 1,300 to 1,800 U for all three proteins, suggesting that the specific activities of these three proteins are about the same. This is in contrast to the results in E. coli, in which NifA-AUG1 from pEH32 accumulated to a lower level than NifA-AUGlac and NifA-AUG2 but produced about the same maximum activity, making it appear to have a higher specific activity than NifA-AUG2 or NifA-AUGlac. The peak of p-galactosidase activity occurred at 0.5 to 1% oxygen, and activity declined rapidly between 1 and 5% oxygen for all three NifA proteins in R. meliloti, falling off most sharply for NifA-AUG1 (Fig.   5D ). At 5% oxygen, only about 7 to 17% of maximum activity remained for all three fusions.
High oxygen prevents accumulation of NifA-AUG1 in E. coli. To investigate the effect of oxygen on NifA accumulation, the levels of NifA-AUGlac, NifA-AVG1, and NifA-AUG2 were compared in E. coli YMC21 and R. meliloti Rm4000 grown at oxygen partial pressures ranging from 0.5 to 21%. In E. coli, NifA-AUG1 accumulation from pSPC32 declined to undetectable levels as the amount of oxygen in the atmosphere was increased to 21%. NifA-AUGlac and NifA-AUG2 in E. coli was not affected by the oxygen level (Fig. 3A) . In R. meliloti, the accumulation of all three NifA proteins was not affected by oxygen levels up to 15% (Fig. 3B ) and declined only slightly at 21% oxygen (data not shown). Since in all cases except for NifA-AUG1 in E. coli increased oxygen produced a decrease in NifA activity without decreasing the amount of NifA protein present, it is likely that one important mechanism governing the loss of NifA activity at high oxygen levels is the inactivation of NifA. However, other mechanisms, such as an altered rate of translation or degradation, may also contribute to a loss of activity for NifA-AUG1 in E. coli. N-terminal domain not required for R. meliloti NifA activity. To confirm previous results (6) suggesting that the poorly conserved N-terminal domain of NifA plays no essential role in oxygen regulation of NifA activity or in the ability of NifA to activate transcription, we constructed pEHAR1, which carries a deletion of the entire N-terminal domain of NifA (Fig. 1B) . The fusion gene carried on this plasmid consists of the lacZ promoter and the first seven codons of lacZ ligated to codon 180 of nifA at the EcoRI site located in the interdomain linker region between the N-terminal and central domains of nifA (17) . The truncated NifA produced from pEHAR1 (NifA-AN) was tested for both its accumulation and its ability to activate transcription from the R. meliloti nipH promoter. NifA-AN accumulated to a high level in E. coli YMC21 at 1% oxygen (Fig. 2B, lane 4; Fig. 6 , lane 2) but declined at oxygen levels of about 5% (Fig. 6, lane 10) . In spite of this decline in accumulation of high oxygen levels, NifA-AN expressed from both high-and low-copy-number vectors was about as active at all oxygen levels as NifAAUGlac in stimulating transcription from the nifl-lacZ fusion carried on pMB210 (Fig. 7A and C) . NifA-AN was also active when tested in R. meliloti but appeared to be about 50% as active as NifA-AUGlac at 1% oxygen and lost activity more rapidly with increasing oxygen than any of the full-length NifAs tested (Fig. SD and 7E ). The accumulation of NifA-AN was extremely low in R. meliloti. We failed to detect NifA-AN by Western blot of total R. meliloti protein (Fig. 3B, lanes 5 and 11) We have addressed this question by deleting the helixturn-helix DNA-binding motif at the C-terminal end of NifA and by testing the deleted protein for its ability to activate transcription from R. meliloti nifH. To create a C-terminaldeleted NifA protein, we ligated a BamHI fragment from pEH32 containing the lacZ promoter fused to the first 489 codons of nifA into the high-copy-number vector pHAT1 to produce pEH200 (Fig. 1B) . Translation of the C-terminaldeleted NifA (NifA-AC) terminates in the polylinker of pHAT1, 2 codons downstream of NifA codon 489. The C-terminal-deleted lacZ'-nifA from pEH200 was also transferred to the broad-host-range plasmid pSPC1 to produce pSPC200. NifA-AC in E. coli YMC21 was undetectable by Coomassie staining (Fig. 2B, lane 6) , suggesting that the level of NifA-AC accumulation is low, like that of NifA-AUG1, the full-length NifA from which it was derived. Unlike NifA-AUG1, NifA-AC was undetectable on Western blots using the antiserum to K. pneumoniae NifA (Fig. 6,  lanes 4, 8, and 12) . It is possible that the C-terminal end of R. meliloti NifA could be required for recognition by this antiserum. NifA-AC was about 50% as effective as NifA-AUG1 in activating expression of the nifH'-lacZ fusion in E. coli YMC21 at 1% oxygen ( Fig. 7B and D) . NifA-AC was capable of stimulating transcription from the nifH'-lacZ fusion carried by R. meliloti Rm4000 at a level about 10-fold lower than that of NifA-AUG1 (Fig. 7F ). This suggests that the C-terminal domain increases the efficiency of activation by NifA but is not essential for NifA activity in E. coli or in R. meliloti.
Central domain of NifA sufficient to activate transcription.
The central domain of NifA contains extensive amino acid homology to other regulatory proteins which activate NtrA-RNA polymerase-dependent promoters. The correlation between the presence of this conserved domain and the requirement for NtrA-RNA polymerase suggests that this conserved central domain could interact with the NtrA-RNA polymerase holoenzyme to stimulate transcription. We tested the ability of the central domain alone to activate the nifH promoter. The plasmid pEH101 carries a doubly deleted nifA gene in which both the N-terminal deletion present in pEHAR1 and the C-terminal deletion present in pEH200 are present in the same nifA gene (Fig. 1B) . The NifA gene product produced from pEH101 (NifA-ANAC) accumulated to about the same level as NifA-AUGlac in E. coli YMC21 (Fig. 2B , lane 5) but was difficult to detect on a Western blot, probably because of a loss of the epitope required for cross-reactivity with the anti-K. pneumoniae NifA antiserum. NifA-ANAC expressed from either high-or low-copynumber plasmids produced about 50% less activity than did NifA-AUGlac (Fig. 7A and C) . In addition, the sensitivity of NifA-ANAC activity to oxygen remained unchanged relative to that of NifA-AUGlac (compare pEH101 with pEH301, Fig. 7A, and pSPC102 with pSPC301, Fig. 7C ).
In contrast to the results obtained in E. coli, only a small amount of NifA-ANAC activity could be detected in R. meliloti Rm4000 (Fig. 7E) . The combination of a 50 to 75% loss of activity due to the N-terminal deletion with a 90% loss of activity due to the C-terminal deletion should decrease NifA activity to 2.5 to 5% of NifA-AUGlac activity, or about 25 to 50 U. The observed activity is within this range, at about 24 U at 0.5% oxygen. E. coli YMC21 was transformed with plasmid DNA isolated from Rm4000 carrying pSPC102 and was retested for NifA activity. No loss in activity was detected relative to that of the original pSPC102 plasmid, ruling out the possibility that pSPC102 had lost NifA activity because of a mutation while in Rm4000. The difficulty of detecting NifAs with C-terminal deletions by using the anti-K. pneumoniae NifA antiserum has prevented us from measuring the amount of NifA-ANAC present in R. The inactivity of the majority of NifA-AUGlac and NifA-AUG2 could be due to a low solubility in the cell. Alternatively, the accumulation of a large amount of inactive protein could be due to a change in protein structure for NifAAUGlac and NifA-AUG2 which blocks the normal degradation of NifA following its inactivation. This hypothesis has the virtue of explaining both why the accumulation rates are different and why the total activity at 1% oxygen from each of the three fusions is the same. In this case, the higher activity of NifA-AUGlac and NifA-AUG2 at 21% oxygen could be due to a small proportion of protein molecules still present which have escaped inactivation. Alternatively, the inactivation by oxygen may be reversible at a low rate. If the inactivation of NifA by oxygen in E. coli is not direct but requires some factor which is in limited supply, titration of such a factor could also be responsible for the higher activity of NifA-AUGlac and NifA-AUG2 at 21% oxygen.
A third explanation is that the concentration of NifA is not the limiting factor for ,-galactosidase expression. If this is the case, the small amount of NifA-AUG1 which accumulates from plasmid pEH32 is sufficient to produce the maximum possible P-galactosidase activity from the nif'-lacZ fusion carried on pMB210, and the excess NifA which accumulates from pEH301 and pEH29 brings about no further increase in ,-galactosidase activity. No increase in ,-galactosidase activity occurred when we reversed the copy numbers of the NifA plasmid and the target promoter by transferring the NifA constructions from a high-copynumber ColEl-based vector (pSDC13) to a low-copy-number RK2-based vector (pSPC1) and assaying them in conjunction with a target nifH'-lacZ fusion on a high-copynumber vector (pEH9) (results shown in Fig. 4B ). Since increasing the ratio of target promoter to NifA did not increase activity, the amount of NifA does not appear to be so high that the amount of activity is proportional only to the number of nifH promoters and is unaffected by changes in the NifA concentration. However, it is difficult to say from this experiment whether the availability of some host component such as NtrA limits the amount of ,B-galactosidase activity regardless of the NifA concentration or whether the rate of ,-galactosidase production is proportional to both the concentration of NifA and the nifW promoter.
Mechanism of oxygen regulation. (32, 37) . Although the conserved N-terminal domain of NtrC and other members of this group regulates protein activity in response to an environmental signal, NifA shares no sequence similarity in its N-terminal domain with NtrC or DctD, making it unlikely that NifA is regulated by the same mechanism. However, NifA could still function in an analogous way with an N-terminal regulatory domain which works by a different mechanism. If the N-terminal domain of NifA has a regulatory function, the signal to which it responds is unknown.
Small alterations at the N terminus of NifA result in greatly increased accumulation, decreased oxygen sensitivity, and decreased specific activity in E. coli but have little effect in R. meliloti. Deletion of the entire N-terminal domain of NifA has no more effect on NifA activity or oxygen regulation than does the addition of a few amino acids from lacZ to the N-terminal end of the full-length protein in E. coli, but in R. meliloti the same deletion causes a considerable decline in NifA accumulation. Although different alterations are required, the accumulation of NifA in both E. coli and R. meliloti can be altered by altering the N-terminal domain. This implicates the N-terminal domain in the control of the translation rate or, more probably, the stability of NifA. An N-end rule has been formulated to explain observed differences in protein stability in eucaryotes which depend on the amino acid present at the amino terminus of the protein, and although the rule has not been tested experimentally in procaryotes, the correlation between the presence of certain amino acids at the amino terminus and a short half-life holds up in procaryotes as well (3) . Since the N-terminal domain of NifA-AUG1 is not sufficient to cause a lower level of accumulation for NifA-AUG1::,B-gal, the low accumulation of NifA-AUG1 cannot be due to an increased rate of protein degradation which is determined solely by the N-terminal end of the protein.
Function of the C-terminal domain. (24) , and the effect of identical point mutations in both UASs upstream of the nifL promoter is suppressed in an allelespecific manner by a mutant NtrC altered in its recognition helix within the C-terminal domain (15) . Also, wild-type K. pneumoniae NifA, but not NifA altered in its recognition helix, protects a UAS upstream of the K. pneumoniae nifH promoter from in vivo methylation (29) , and the C-terminal domain is sufficient for methylation protection of the UAS (30) . However, a small amount of activity remains in K. pneumoniae NifA from which the C-terminal domain has been deleted (30) .
Both K. pneumoniae NifA (9, 30) and R. meliloti NifA (3), as well as NtrC (24, 34) , are capable of activating their target promoters to some degree in the absence of a UAS. This may reflect the ability of this group of activators to substitute cryptic UAS sequences or nonspecific DNA for the missing UAS. Alternatively, these activators could interact directly with the NtrA-RNA polymerase at the promoter or with the DNA of the promoter itself to activate transcription. If, as seems likely, the C-terminal domain of R. meliloti NifA is the portion of the protein which contacts the UAS, the activity of NifA-AC suggests that at least in this case activation of transcription does not require binding to DNA upstream of the target promoter. Our results are consistent with a model for transcriptional activation in which NifA directly contacts the NtrA-RNA polymerase holoenzyme and DNA sequences at the promoter to stimulate transcription and in which the role of the UAS is to increase the local concentration of NifA near the target promoter. Such a model has been proposed for transcriptional activation by NifA (1, 8, 30) . This model is also consistent with results obtained for in vitro transcriptional activation by NtrC which show that the effect of deleting all UAS sequences upstream of the gInAp2 promoter can be overcome by increasing the concentration of NtrC by about fourfold (24) .
Function of the central domain. A doubly deleted protein from which both the entire N-terminal domain and the C-terminal helix-turn-helix motif had been removed (NifA-ANAC) was about as oxygen sensitive and about 50% as active in stimulating transcription from the nifH promoter as the full-length protein in E. coli. This doubly deleted NifA consists of the highly conserved central domain shared by NtrC and DctD and a poorly conserved region of 50 amino acid residues located between the central domain and the C-terminal domain. The presence of four invariant cysteine residues, three of which are present in all NifAs from symbiotic nitrogen-fixing species but not in NifA from K. pneumoniae, may be responsible for the oxygen sensitivity of symbiotic NifAs (18) . This hypothesis is consistent with the present results, since all four cysteines are still present in the doubly deleted NifA.
The transcriptional activity of NifA-ANAC is consistent with our prediction that the core domain is the part of NifA which interacts with the transcriptional machinery to stimulate transcription. Also consistent with this prediction is the recent discovery of HrpS, a naturally occurring example from Pseudomonas syringae of a protein that consists of a NifA-like central domain and only a few additional amino acids (C. Grimm and N. Panopoulos, personal communication). An interaction between the helix-turn-helix at the C-terminal end of NifA and the UAS of a target promoter is likely to be an important determinant of the specificity of NifA for activation of the nijfH promoter. If such an interaction takes place between the C-terminal domain of NifA and the UAS of its target promoters, the specificity of NifA with an altered or deleted C-terminal domain for a subset of NtrA-requiring promoters may be altered, and we are in the process of testing this possibility.
